Contravisory Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-296
| Closed | -$81.4K | – | 434 |
|
|
2025
Q4 | $81.4K | Buy |
+296
| New | +$81K | 0.02% | 254 |
|
|
2025
Q2 | – | Sell |
-75
| Closed | -$16.8K | – | 456 |
|
|
2025
Q1 | $16.8K | Hold |
75
| – | – | ﹤0.01% | 322 |
|
|
2024
Q4 | $24.6K | Hold |
75
| – | – | 0.01% | 267 |
|
|
2024
Q3 | $22.5K | Hold |
75
| – | – | ﹤0.01% | 270 |
|
|
2024
Q2 | $24.7K | Hold |
75
| – | – | 0.01% | 242 |
|
|
2024
Q1 | $29.7K | Sell |
75
-1,604
| -96% | -$593K | 0.01% | 259 |
|
|
2023
Q4 | $591K | Buy |
1,679
+1,579
| +1,579% | +$559K | 0.14% | 94 |
|
|
2023
Q3 | $37.5K | Hold |
100
| – | – | 0.01% | 234 |
|
|
2023
Q2 | $38.2K | Hold |
100
| – | – | 0.01% | 227 |
|
|
2023
Q1 | $34.6K | Hold |
100
| – | – | 0.01% | 236 |
|
|
2022
Q4 | $23.5K | Hold |
100
| – | – | 0.01% | 244 |
|
|
2022
Q3 | $25K | Hold |
100
| – | – | 0.01% | 246 |
|
|
2022
Q2 | $30K | Sell |
100
-293
| -75% | -$95.3K | 0.01% | 245 |
|
|
2022
Q1 | $161K | Sell |
393
-181
| -32% | -$70.9K | 0.05% | 202 |
|
|
2021
Q4 | $269K | Buy |
574
+207
| +56% | +$89.1K | 0.07% | 171 |
|
|
2021
Q3 | $156K | Sell |
367
-12
| -3% | -$5.06K | 0.05% | 193 |
|
|
2021
Q2 | $136K | Sell |
379
-1,127
| -75% | -$372K | 0.04% | 196 |
|
|
2021
Q1 | $424K | Sell |
1,506
-63
| -4% | -$18K | 0.13% | 86 |
|
|
2020
Q4 | $445K | Buy |
1,569
+136
| +9% | +$38.2K | 0.14% | 75 |
|
|
2020
Q3 | $394K | Buy |
1,433
+104
| +8% | +$27.5K | 0.13% | 79 |
|
|
2020
Q2 | $280K | Hold |
1,329
| – | – | 0.1% | 115 |
|
|
2020
Q1 | $202K | Buy |
1,329
+55
| +4% | +$8.47K | 0.09% | 126 |
|
|
2019
Q4 | $192K | Buy |
1,274
+171
| +16% | +$24.9K | 0.07% | 145 |
|
|
2019
Q3 | $156K | Hold |
1,103
| – | – | 0.06% | 151 |
|
|
2019
Q2 | $138K | Hold |
1,103
| – | – | 0.05% | 155 |
|
|
2019
Q1 | $122K | Sell |
1,103
-130
| -11% | -$13.5K | 0.05% | 171 |
|
|
2018
Q4 | $121K | Buy |
+1,233
| New | +$134K | 0.05% | 166 |
|
|
2018
Q2 | – | Sell |
-1,892
| Closed | -$167K | – | 374 |
|
|
2018
Q1 | $167K | Sell |
1,892
-60
| -3% | -$5.61K | 0.06% | 159 |
|
|
2017
Q4 | $193K | Sell |
1,952
-165
| -8% | -$16.2K | 0.07% | 149 |
|
|
2017
Q3 | $204K | Hold |
2,117
| – | – | 0.07% | 146 |
|
|
2017
Q2 | $200K | Hold |
2,117
| – | – | 0.07% | 135 |
|
|
2017
Q1 | $173K | Hold |
2,117
| – | – | 0.06% | 123 |
|
|
2016
Q4 | $180K | Hold |
2,117
| – | – | 0.06% | 79 |
|
|
2016
Q3 | $158K | Hold |
2,117
| – | – | 0.05% | 75 |
|
|
2016
Q2 | $161K | Hold |
2,117
| – | – | 0.05% | 71 |
|
|
2016
Q1 | $147K | Sell |
2,117
-568
| -21% | -$34.2K | 0.04% | 79 |
|
|
2015
Q4 | $162K | Hold |
2,685
| – | – | 0.04% | 83 |
|
|
2015
Q3 | $145K | Hold |
2,685
| – | – | 0.03% | 79 |
|
|
2015
Q2 | $156K | Buy |
+2,685
| New | +$150K | 0.03% | 87 |
|
Other funds holding WST
GIM
Contravisory Investment Management's WST Position: Q1 2026 in Review
Contravisory Investment Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 296 shares — an estimated $81.4K sold.
Contravisory Investment Management first reported a position in WST in Q2 2015 and held it in 39 quarters. The position peaked at $591K in Q4 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Contravisory Investment Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- Contravisory Investment Management sold 296 West Pharmaceutical shares in Q1 2026, an estimated $81.4K.
- Contravisory Investment Management first reported a position in West Pharmaceutical in Q2 2015 and held it in 39 quarters.
- Contravisory Investment Management's West Pharmaceutical position peaked at $591K in Q4 2023.
- 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.